NCT04756596

Brief Summary

Primary objective of this study is the development and validation of a web-based application for the examination of the distance visual acuity of normal- and low-vision patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

February 12, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 16, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

November 16, 2021

Status Verified

November 1, 2021

Enrollment Period

1.3 years

First QC Date

February 12, 2021

Last Update Submit

November 13, 2021

Conditions

Keywords

web applicationdistance visual acuitysmart featuresface detectiontext calibration

Outcome Measures

Primary Outcomes (2)

  • Distance visual acuity using DDVIT vision test

    The distance visual acuity of the one randomly selected eye of each participant will be evaluated by the examiner using DDVIT vision test.

    4 months

  • Distance visual acuity using ETDRS vision test

    The distance visual acuity of the same eye of each participant will be evaluated by the same examiner using the web-based ETDRS vision test under the same predetermined environmental lighting conditions.

    4 months

Study Arms (1)

Study group

70 patients with normal vision (NVG) 30 patients with low vision (LVG) These patients will be tested on the DDVIT

Diagnostic Test: DDVIT testingDiagnostic Test: ETDRS testing

Interventions

DDVIT testingDIAGNOSTIC_TEST

One randomly selected eye will be included for each study participant. Participants respond to the DDVIT test in standard environmental lighting conditions at 4 m viewing distance. Visual acuity will be evaluated.

Study group
ETDRS testingDIAGNOSTIC_TEST

The same eye is included for each study participant. Participants respond to the standard ETDRS chart of our Ophthalmology Department in standard environmental lighting conditions at 4 m viewing distance. Visual acuity will be evaluated.

Study group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Normal- and low-sighted participants aged 18 to 75 years.

You may qualify if:

  • Patients of our outpatient ophthalmology clinic
  • Age between 18 to 75 years

You may not qualify if:

  • Dyslexia
  • Attention-deficiency
  • Former diagnosis of mental and/or psychiatric diseases
  • Inability to cooperate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Ophthalmology, University Hospital of Alexandroupolis

Alexandroupoli, Evros, 68100, Greece

RECRUITING

Department of Computer Science and Biomedical Informatics, University of Thessaly

Lamía, Thessaly, 35100, Greece

NOT YET RECRUITING

MeSH Terms

Conditions

Refractive ErrorsVision, LowVision Disorders

Condition Hierarchy (Ancestors)

Eye DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Georgios Labiris, MD, PhD

    Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece

    STUDY CHAIR

Central Study Contacts

Georgios Labiris, MD, PhD

CONTACT

Eirini - Kanella Panagiotopoulou, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
15 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor (Associate) of Democritus University of Thrace

Study Record Dates

First Submitted

February 12, 2021

First Posted

February 16, 2021

Study Start

February 1, 2021

Primary Completion

May 31, 2022

Study Completion

June 30, 2022

Last Updated

November 16, 2021

Record last verified: 2021-11

Locations